Sign in
CompletedNo phase

A4i-O: A Platform for Complex Behavioral Health to Address OUD

Key facts

Who runs it
Centre for Addiction and Mental Health
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
14 people enrolled
Started
5 Feb 2024
Ended
1 Nov 2024
Type of study
Interventional
Treatments tested
  • App for Independence-O (A4i-O)
Record updated
22 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Participants will be adults, 18 years of age or older, with a provider-assigned diagnosis of OUD confirmed by the SCID-5. Electronic medical records will be accessed for CAMH clients after informed consent is obtained to confirm the OUD diagnosis. For clients who were recruited externally and do not have a CAMH chart, confirmation of diagnosis will be sought from the referring clinician
  • All participants will be engaged in outpatient psychiatric treatment for OUD
  • All participants will currently be engaged in opioid agonist treatment
  • Proficiency in English via ability to understand written/verbal communication during consent process. Any RA concerns about ability to understand English will be brought to the PI for determination of next steps (see consent procedures below)
  • Own and use an Android or iOS smartphone
  • All participants will be open to having their care provider participate in the study

Who cannot take part

  • Lack of capacity to consent
  • Intellectual disability
  • Experiencing distress at a level that would affect research and technology engagement (e.g., acute suicidality); Criteria (service providers): Service providers will be psychiatrists and case managers engaged in the care of the participants

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

For the purposes of beta testing the first version of A4i-O, 15 individuals with OUD will use the platform for one month. From a design perspective this sample size is viewed as being sufficient to answer questions regarding app functionality and feasibility before moving to larger trials. Additionally, 15 individuals is a larger sample size than in the A4i pilot. This is an open label pilot with a primary objective of troubleshooting and providing early feedback on the beta version of the technology. To that end, 15 participants are anticipated to be sufficient to provide robust, early feedback. As with the focus groups, through sampling an effort will be made to secure a diverse group. Any individuals who might be declined in that effort at this stage (e.g., it is determined that no more male identifying participants are needed but they were interested) would be invited to take part in the subsequent RCT.

The group in the trial

  • App for Independence-O (A4i-O)Treatment being tested

    Participants will be provided with A4i-O for one month.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
App for Independence-O (A4i-O) - Expanding a Validated Platform for Complex Behavioral Health to Address Opioid Use Disorder
Record updated
22 April 2026